Home/Filings/4/A/0000930413-04-003571
4/A//SEC Filing

BERK BERNARD 4/A

Accession 0000930413-04-003571

CIK 0001053369other

Filed

Aug 9, 8:00 PM ET

Accepted

Aug 10, 6:17 PM ET

Size

12.0 KB

Accession

0000930413-04-003571

Insider Transaction Report

Form 4/AAmended
Period: 2004-08-09
BERK BERNARD
DirectorChief Exec. Officer & Chairman
Transactions
  • Purchase

    Common Stock

    2004-08-09$1.35/sh+3,000$4,05064,500 total
  • Purchase

    Common Stock

    2004-08-10$1.45/sh+3,400$4,93064,500 total
  • Purchase

    Common Stock

    2004-08-09$1.45/sh+6,700$9,71564,500 total
  • Purchase

    Common Stock

    2004-08-09$1.34/sh+300$40264,500 total
  • Purchase

    Common Stock

    2004-08-10$1.50/sh+1,600$2,40064,500 total
  • Purchase

    Common Stock

    2004-08-10$1.55/sh+9,500$14,72564,500 total
Footnotes (1)
  • [F1]This amount does not include 630,000 options which have been previously granted to the Reporting Person.

Documents

1 file

Issuer

ELITE PHARMACEUTICALS INC /DE/

CIK 0001053369

Entity typeother

Related Parties

1
  • filerCIK 0001280942

Filing Metadata

Form type
4/A
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 6:17 PM ET
Size
12.0 KB